Publications by authors named "Elham Assareh"

Claim this Profile
A
A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities.
Mohadeseh Namjoo, Hossein Ghafouri, Elham Assareh, Amir Reza Aref, Ebrahim Mostafavi

Pharmaceuticals (Basel)· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination Therapy in Cancer: Doxorubicin in Combination with an N-terminal Peptide of Endostatin Suppresses Angiogenesis and Stimulates Apoptosis in the Breast Cancer.
Narges Sarabi, Reyhane Chamani, Elham Assareh, Omid Saberi, S Mohsen Asghari

Int J Mol Cell Med· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor and anti-metastatic activity of the FGF2 118-126 fragment dependent on the loop structure.
Hossein Allahmoradi, S Mohsen Asghari, Atieh Ahmadi, Elham Assareh, Mahboobeh Nazari

Biochem J· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Studies on an Anti-Angiogenic Peptide Using Molecular Modeling.
Elham Assareh, Faramarz Mehrnejad, S Mohsen Asghari

Iran J Biotechnol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth.
Elham Assareh, Faramarz Mehrnejad, Kamran Mansouri, Ahmad Reza Esmaeili Rastaghi, Hossein Naderi-Manesh

Biochem J· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis